Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2463836018 | Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2469028017 | Dexamethasone+neomycin sulfate+polymyxin b sulphate 0.1%wv/3.5mg/10000unt suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2469507017 | Dexamethasone+neomycin sulfate+polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2871318012 | Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2871319016 | Dexamethasone + neomycin sulphate + polymyxin b sulphate 0.1%wv/3.5mg/10000unt suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | est un(e) (attribut) | Product containing neomycin (medicinal product) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | est un(e) (attribut) | dexaméthasone | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | est un(e) (attribut) | Ophthalmic antibiotic (product) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | est un(e) (attribut) | Compound neomycin preparations (product) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | est un(e) (attribut) | Product containing neomycin in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | est un(e) (attribut) | Product containing polymyxin B (medicinal product) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Dexamethasone (substance) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Polymyxin B (substance) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Topical neomycin (substance) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | est un(e) (attribut) | médicament contenant dexaméthasone et néomycine et polymyxine B | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Neomycin sulfate | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Skin anti-infective (substance) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Polymyxin B sulfate | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Corticosterone | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Adrenal hormone agent (substance) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Local anti-infective (substance) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a pour principe actif (attribut) | Bactericide | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage oculaire (forme pharmaceutique) | false | Inferred relationship | Some | ||
| Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension (product) | a une forme pharmaceutique (attribut) | Suspension | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR